End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.29 CNY | -4.70% | -8.16% | -33.48% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 50% by 2026.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Weaknesses
- The firm trades with high earnings multiples: 26.38 times its 2024 earnings per share.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Office Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-33.48% | 217M | - | ||
+4.77% | 7.73B | B- | ||
-6.99% | 4.59B | B | ||
-2.72% | 2.99B | - | ||
+8.51% | 2.21B | - | ||
-31.85% | 1.05B | - | ||
+16.32% | 1.05B | C+ | ||
+8.13% | 914M | - | ||
-51.71% | 800M | - | ||
-19.42% | 722M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688056 Stock
- Ratings Beijing Labtech Instruments Co., Ltd.